You had searched for:

There were no results matching the query.

You can also browse the topics below to find what you are looking for.

Support Services

  1. Download the Prescription and Service Request Form (PSRF)
  2. Fax the completed form to Shared Solutions® at 1-844-257-6127

Patients can call 1-800-887-8100, Monday–Friday, 8 am–6 pm CT.

Flexibility to help you meet your patients’ needs1

Dosed Circle

DOSED1

AJOVY is the only approved anti-CGRP preventive migraine treatment with quarterly and monthly dosing options

Quarterly dosing option for AJOVY

Only 4 injection days per year with quarterly dosing 675 mg (225 mg x 3) SQ

 

or

Monthly dosing option for AJOVY

Only 1 injection per month with monthly dosing 225 mg SQ

 

Patients who previously participated in the clinical trials of AJOVY were recruited to complete an online survey.*

Patient dosing survey chart

Nearly 70% of people reported that they would choose quarterly dosing instead of monthly dosing.1*

*253 chronic and episodic migraine patients who previously participated in clinical trials were recruited to complete an online survey. Patients, blinded as to whether they received monthly or quarterly injections of AJOVY, were asked, "Would you rather take the injectable migraine medicine as 1 injection once a month or 3 injections once every 3 months?" 69% of respondents said they would rather take the quarterly dosing option and 31% said they would rather take the monthly dosing option.1

Administered Circle

ADMINISTERED1

In office

by a healthcare professional

or

At home

by patient or caregiver

Guidance on proper subcutaneous administration techniques should be provided.

Studied Circle

STUDIED1

Alone and in combination with oral preventive treatments

  • 1000+ patients received AJOVY as a stand-alone preventive treatment
  • 280+ patients continued to receive their oral preventive treatment
Reflects Circle

Reflects

Real-world patients

  • Phase 3 trials enrolled nearly 600 patients that had discontinued prior preventive treatment2

  • 18% of women of childbearing age also took concomitant hormonal contraceptives2

There are no adequate data on the developmental risk associated with the use of AJOVY in pregnant women. AJOVY has a long half-life. This should be taken into consideration for women who are pregnant or plan to become pregnant while using AJOVY.1

Support Services

  1. Download the Prescription and Service Request Form (PSRF)
  2. Fax the completed form to Shared Solutions® at 1-844-257-6127

Patients can call 1-800-887-8100, Monday–Friday, 8 am–6 pm CT.

Suggestions to explore next

Continue to AJOVY Efficacy page

AJOVY helped significantly reduce monthly migraine days vs placebo1

See the clinical trial data for AJOVY
Continue to AJOVY Patient Support page

Savings Offer coupon for AJOVY

Learn how much AJOVY may cost eligible patients

Safety profile in clinical trials for AJOVY1

SIDE EFFECTS OF AJOVY